Business Review Board

The Business Review Board reviews grants applications by biotechnology companies. It comprises members from various backgrounds, including venture capital and the biotechnology and pharmaceutical industries.

  • Denise Barbut, MD, MRCP
    Sarentis Therapeutics, Inc

  • Thomas Cirrito, PhD
    Stemline Therapeutics, Inc.

  • Mark A. Cochran, PhD
    Johns Hopkins University School of Medicine

  • Steven G. Dickman
    CBT Advisors

  • Stephen M. Goodman, JD
    Pryor Cashman Sherman & Flynn, LLP

  • Allan M. Green, MD, PhD, JD
    Allan M. Green Esq., LLC

  • Emer Leahy, PhD, MBA
    Psychogenics Inc.

  • Michael Lefenfeld
    SiGNa Chemistry, Inc.

  • David Lowe, PhD
    NeuroAssets

  • Brian McCarthy, PhD
    Influmedix, Inc.

  • Ian J. Mehr, PhD, MBA
    Golden Pine Ventures, LLC

  • Michael Parker, MBA
    BioAsset Advisors

  • Rana Quraishi, PhD
    Capco

  • Teresa Reguly, PhD, JD
    Torys LLP

  • Cheryl V. Reicin, JD
    Torys LLP

  • Danny Talati, Pharm.D.
    Fortress Biotech

  • Martin Tolar, MD, PhD
    Alzheon, Inc.

  • Katya Tsaloun, PhD
    Cyprotex